| MEDI | Wednesday, August 22, 2007 | ||
1:30 PM-4:25 PM BCEC -- 210A, Oral | |||
Palliative Approaches to the Treatment of Alzheimer's Disease | |||
| Presiding: | Albert J Robichaud | ||
| 1:30 PM | 256 | Design and synthesis of potent 5-HT6 ligands for cognitive impairment Hassan Elokdah, Kevin Liu, Derek Cole, Ronald C Bernotas, Ronald L Magolda, Lee E. Schechter, Guo Ming Zhang, Deborah Smith, Albert J Robichaud | |
| 2:05 PM | 257 | Novel potent and selective inverse agonists at the GABAA a5 receptor sub-type A W Thomas, T M Ballard, F Blasco, T Buttelmann, H Fischer, M-C Hernandez, F Knoflach, H Knust, R Moog, H Stadler, G Trube, P Waldmeier, M Wooley | |
| 2:40 PM | 258 | Design, synthesis, and SAR of azabicyclic aryl amides as a7 nicotinic acetylcholine receptor agonists for the treatment of cognitive deficits in schizophrenia and Alzheimer's disease: Discovery of PHA-543,613 Donn G Wishka | |
| 3:15 PM | 259 | 5-HT1A Antagonists as cognitive enhancers: The discovery of lecozotan Wayne E. Childers Jr., Boyd L. Harrison | |
| 3:50 PM | 260 | Histamine H3 receptor antagonists: Potential to address CNS deficits of memory, cognition, and attention Marlon D. Cowart | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 234th ACS National Meeting, Boston, MA, August 19-23, 2007